Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations Update

1 Aug 2014 07:00

RNS Number : 9651N
3Legs Resources plc
01 August 2014
 



For Immediate Release

 

1 August 2014

 

 

3Legs Resources plc

 

Operations update

 

3Legs Resources plc ('3Legs' or 'the Company'), an independent oil and gas group focusing on the exploration and development of unconventional oil and gas resources in Poland, announces the following operations update.

 

Highlights:

 

Baltic Basin: Lublewo LEP-1ST1H lateral well 

· Multi-stage stimulation has now been successfully completed as planned.

· Stimulation comprised 25 stages using a high quality white sand proppant; 7.7 million lbs of proppant delivered over the 25 stages.

· The Company believes this is the largest multi-stage shale stimulation executed to date in Poland.

· The well is now being prepared for clean-up and testing, due to commence shortly.

 

Operations update

 

The multi-stage stimulation of the Lublewo LEP-1ST1H lateral well was commenced on 15 July and has now been successfully completed, in accordance with plan. The programme comprised 25 stages and was executed across 1,469 metres out of the available 1,495 metres of lateral section. This compares with the Lebien LE-2H well, the last lateral well drilled by 3Legs which also targeted the Sasino shale horizon, where a 1,000 metre lateral section was stimulated in 2011 with a 13-stage programme.

 

Approximately 310,000 lbs of high quality white sand were used per stage, equivalent to some 7.7 million lbs over the 25 stages of the stimulation. This compares with 220,000 lbs of sand per stage, or 2.9 million lbs in total, used in the Lebien LE-2H well in 2011. The fluid used was a cross-linked gel, as compared with a slickwater fluid which was used on the Lebien LE-2H well in 2011. The use of a cross-linked gel was designed to reduce the amount of fluid required per stage, while maximising proppant delivery.

 

The stimulation programme - believed to be the largest multi-stage shale stimulation executed to date in Poland - incorporated the extensive learnings that 3Legs and ConocoPhillips have acquired since first commencing shale drilling operations in Poland's Baltic Basin, in 2010. Over that period, the two companies have drilled a total of eight wells in the basin targeting two different shale horizons, including three long length lateral wells, and they have executed stimulation programmes on six of these wells.

 

The well is now being prepared for clean-up and long term testing, due to commence shortly, when further announcements will be made.

 

Kamlesh Parmar, Chief Executive of 3Legs Resources,said:

 

"We are now into the final phase of our 2013/14 drilling programme, namely the stimulation and testing of our long lateral section at the Lublewo LEP-1ST1H well. We are confident that we have incorporated all the available learnings we have acquired to date into the design and execution of the stimulation programme, and that we have taken all steps to ensure that the forthcoming well test has every chance of success. We are pleased to be continuing to implement our 2013/14 drilling programme on time and as announced last November, and we look forward to sharing further news with the market in due course."

 

For further information contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Kamlesh Parmar, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies Hoare Govett

Tel:

+44 207 029 8000

Simon Hardy

Graham Hertrich

Northland Capital Partners

Tel:

+44 207 382 1100

Louis Castro

Matthew Johnson

FTI Consulting

Tel:

+44 207 831 3113

Oliver Winters

Shannon Brushe

 

Notes to Editors

 

3Legs Resources plc is an independent oil and gas group focused on the exploration and development of unconventional oil and gas resources. 3Legs Resources holds interests in six licences covering approximately 1,084,000 acres (gross) in the onshore Baltic Basin in northern Poland, a region considered to be one of the most promising shale basins in Europe.

 

The technical information and opinions contained in this announcement have been reviewed by Christie Ward Schultz (BSc in Petroleum Engineering, Texas Tech University), Engineering Manager of 3Legs Resources plc, who has over 14 years of experience in the oil exploration and production industry. She has consented to the inclusion herein of such technical information and opinions.

 

www.3legsresources.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCGDRXUXBGSB
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.